Majesco Entertainment Company Stock News

NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of PolarityTE, Inc. (NASDAQ: PTE) between April 30, 2020 and August 23, 2021, inclusive (the Class Period), of the important November 23, 2021 lead plaintiff deadline .

Brickell Biotech, Inc. (BBI) with the stream of 3.72% also noticed, India PolarityTE, Inc. (PTE) encountered a rapid change of 1.43% in the last hour of Fridays trading session. Brickell The post Take This As A Wake-Up Call: Brickell Biotech, Inc. (NASDAQ:BBI), PolarityTE, Inc. (NASDAQ:PTE) appeared first on Stocks Equity .

(PR-inside.com) LOS ANGELES, CA / ACCESSWIRE / November 19, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PolarityTE, Inc. ("PolarityTE" or "the Company") (NASDAQ:PTE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company''s securities between April 30, 2020 and August 23, 2021, inclusive (the ''''Class Period''''), are encouraged to contact the firm before November 23, 2021. If you are a shareholder who suffered a loss, click here to participate. We also ..

Pomerantz LLP announces that a class action lawsuit has been filed against PolarityTE, Inc. and certain of its officers. The class action, filed in the United States District Court for the District of Utah, and docketed under 21-cv-00561, is on behalf of a class []

Celsion Corporation (CLSN) with the stream of -3.48% also noticed, India PolarityTE, Inc. (PTE) encountered a rapid change of 0.70% in the last hour of Tuesdays trading session. Celsion Corporation The post Up to Date Trending Stock: Celsion Corporation (NASDAQ:CLSN), PolarityTE, Inc. (NASDAQ:PTE) appeared first on Stocks Equity .

Zacks Investment Research upgraded shares of PolarityTE (NASDAQ:PTE) from a hold rating to a buy rating in a research note released on Tuesday, Zacks.com reports. The brokerage currently has $0.75 target price on the stock. According to Zacks, PolarityTE, Inc. creates regenerative medicine and provides tissue engineering platform. It develops and obtains regulatory approval for []

NEW YORK, Nov. 14, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of PolarityTE, Inc. (NASDAQ: PTE) between April 30, 2020 and August 23, 2021, inclusive (the Class Period), of the important November 23, 2021 lead plaintiff deadline .